Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the relative risks and benefits of two approaches to
the control of weight gain and other negative side effects in children and adolescents on 2nd
generation antipsychotics (SGA):
- Healthy lifestyle instruction (nutritional and physical activity surveillance and
advice) + continuation of current SGA;
- Add the diabetes drug, metformin + continuation of current SGA.